Lactase enzyme trials recruiting now

1 registration that name lactase enzyme as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 1 registration

Status

All 1 registrations

RecruitingNCT07088302

Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates

  • No phase
  • Alexandria University
  • About 120 people
  • Started Aug 30, 2025

In plain words A study of lactase enzyme in people 3 days to 1 month, run by Alexandria University. It plans to enroll about 120 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 3 days to 1 month. Conditions: Premature; Feeding Disorders; Lactase Deficiency, Congenital.

  • Preterm neonates ≤ 32 weeks gestational age.
  • Start feeding in the first 72 hours of life. 8. Exclusion criteria
  • Parental consent lacking/refusal.
  • Obvious major congenital abnormalities.

4 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

lactase administration; placebo

Registered summary

This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.

Where, as registered

No US site; Egypt (1).

ClinicalTrials.gov lists 6 open registrations for this search, including ones where lactase enzyme is not a study arm or that are past the 1 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.